By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German molecular diagnostics firm Epigenomics today reported that its first-half revenues increased 1 percent year over year, and the firm is implementing a restructuring that will include cutting its staff by nearly half.

The Berlin-based firm reported first-half revenues of €990,000 ($1.4 million), compared to €970,000 for the first half of 2010. Its net loss increased 10 percent to €5.90 from €5.40.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.